Back to today’s briefing

Story perspectives

Breakthrough Antibiotic Cures 92.6% of Gonorrhea Cases

4/27/2025

50 4

Summary

Story summary

A groundbreaking antibiotic, gepotidacin, has emerged as a potential game-changer in the fight against drug-resistant gonorrhea, successfully curing 92.6% of 628 trial participants worldwide. This could mark the first new treatment in over three decades. Additionally, researchers have discovered NQNO, a compound that prompts gonococci to self-destruct, providing renewed hope against antibiotic resistance.

1 of 1

Story summary

A groundbreaking antibiotic, gepotidacin, has emerged as a potential game-changer in the fight against drug-resistant gonorrhea, successfully curing 92.6% of 628 trial participants worldwide. This could mark the first new treatment in over three decades. Additionally, researchers have discovered NQNO, a compound that prompts gonococci to self-destruct, providing renewed hope against antibiotic resistance.